Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 35 out of 100. Mild cognitive impairment

Topic: Amyloid, tau and blood-test diagnosis

ABSTRACT Accurate prediction of the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is essential for early intervention and effective disease management. This study introduces an interpretable multi‐modal framework that integrates structural Magnetic Resonance Imaging (sMRI) features and neurocognitive clinical assessments through a hybrid deep learning and machine learning approach to predict progressive MCI (pMCI) conversion up to 3 years in advance. Cross‐sectional data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) were employed. Spatial features were extracted from sMRI scans using a three‐dimensional convolutional neural network (3D CNN), while statistically selected neurocognitive assessments constituted the clinical feature set. These features were fused and classified using machine learning models, including Random Forest (RF), Logistic Regression (LR), Support Vector Machine (SVM), and Gradient Boosting Machine (GBM). Model interpretability was evaluated using SHapley Additive Explanations (SHAP). The proposed multi‐modal framework achieved a classification accuracy of 88.11%, an area under the curve (AUC) of 0.889, a precision of 82.33%, a sensitivity of 90.52%, and a specificity of 78.59%. The GBM classifier demonstrated superior performance by effectively integrating imaging and clinical features. SHAP analysis identified critical biomarkers influencing prediction outcomes, and the model exhibited strong generalizability across diverse clinical sites and imaging protocols. Consequently, this study presents a robust and interpretable framework for the early prediction of MCI conversion to AD. By combining deep learning‐derived imaging features with neurocognitive assessments, the proposed method offers a promising tool to support early diagnosis and targeted intervention strategies in clinical practice.

Key findings

Why it matters

A hybrid deep learning and machine learning framework combining structural MRI and neurocognitive assessments predicted conversion from mild cognitive impairment to Alzheimer's disease up to three years in advance with 88.11% accuracy. This is a prediction tool, not a treatment, cure or prevention.

Study details

How this study scored 35/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 35 of 100.35 of 100 points earned65 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (International Journal of Imaging Systems and Technology)
Journal's citation record 1 / 4 International Journal of Imaging Systems and Technology: journal h-index 77 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Ahmad Shalbaf: h-index 27 (OpenAlex, whole career)
Institution's track record 0 / 3 Shahid Beheshti University of Medical Sciences: institution h-index 381 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 35 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Zarei, S., Saffar, M., Hassani‐Abharian, P., Shalbaf, R., & Shalbaf, A. (2026). Predicting Mild Cognitive Impairment to Alzheimer's Disease Progression by Explainable Multi‐Modal Framework Using Deep and Machine Learning Hybrid Model. International Journal of Imaging Systems and Technology. https://doi.org/10.1002/ima.70390

Vancouver

Zarei S, Saffar M, Hassani‐Abharian P, Shalbaf R, Shalbaf A. Predicting Mild Cognitive Impairment to Alzheimer's Disease Progression by Explainable Multi‐Modal Framework Using Deep and Machine Learning Hybrid Model. International Journal of Imaging Systems and Technology. 2026. doi:10.1002/ima.70390.

BibTeX

@article{zarei2026-b3a80709,
  author  = {Zarei, Soheil and Saffar, Mohsen and Hassani‐Abharian, Peyman and Shalbaf, Reza and Shalbaf, Ahmad},
  title   = {{Predicting Mild Cognitive Impairment to Alzheimer's Disease Progression by Explainable Multi‐Modal Framework Using Deep and Machine Learning Hybrid Model}},
  journal = {International Journal of Imaging Systems and Technology},
  year    = {2026},
  doi     = {10.1002/ima.70390},
  url     = {https://doi.org/10.1002/ima.70390}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.

Related studies in Mild cognitive impairment

Also tagged “assessment”

840 studies in the library carry the topic tag “assessment”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →